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1. Introduction 
The design of catalysts able to perform the heteroatom-
acylation of alkynes, forming in a regio-, stereoselective and 
simultaneous manner a carbon-carbon and a carbon-heteroatom 
bonds, is extremely challenging.
1
 The interest of this reaction is 
not only a matter of the intrinsic process but also of the final 
products. Thus, the addition of acid chlorides to alkynes gives β-
chlorovinyl ketones,
2
 which are a class of compounds very useful 
for the synthesis of a variety of other compounds. 
The initial use of stoichiometric amounts of aluminum 
derivatives, as Lewis acids, for the Friedel-Crafts addition of acyl 
chlorides to alkynes showed a very low selectivity, with the E-
isomer being the major product.
3
 The replacement of the 
aluminum catalyst to silver perchlorate,
4
 gallium trichloride,
5
 or 
zinc oxide
6
 did not change so much the initial picture of this 
process. This fact favored the introduction of typical transition 
metal complexes, such as those derived from rhodium
7
 or 
iridium.
8
 These new complexes permitted the reduction of the 
catalyst amount from stoichiometric to 5-1 mol%, obtaining only 
the Z-chlorovinyl ketone isomer. However, these catalysts have 
new drawbacks, such as their inherent toxicity, their handling 
difficulty, their instability, high price, the CO extrusion from 
reagents depending on the catalyst, and their no-reactivity with 
internal alkynes.
 
Very recently, different iron salts (FeBr2
9
 and FeCl3
10
) have 
been introduced as a convenient, inexpensive, environmentally 
friendly and practical catalyst alternative. In our ongoing project 
on the use of magnetite as an efficient catalyst for different 
organic reactions,
11
 we anticipated that it could be a new and 
sustainable alternative for this process. Herein, we wish to 
describe its use as valuable catalyst for the addition of acid 
chlorides to poor reactive internal alkynes leading to the 
formation of chlorovinyl ketones, cyclopenta[a]naphthalen-1-
ones, 5-chloro-4-arylcyclopent-2-enones, and 2,3,5-trisubstituted 
furans, depending on the nature of the substrates.  
2. Results and discussion 
2.1. Chloroacylation Process 
Since the reaction with internal alkynes is either unknown 
using rhodium, iridium, gallium trichloride and iron dibromide 
derivatives or yields a very low isomeric ratio for the iron 
trichloride-catalyzed reaction
10
 (with the E/Z ratio being 2.2/1), 
the addition of benzoyl chloride (1a) to dec-5-yne (2a) was 
chosen as model (Table 1). The first trial was carried out in 
absence of any catalyst to prove the real activity of iron oxide 
(entry 1), and after several hours the reaction failed recovering 
the unchanged alkyne 2a. However, a similar reaction but 
conducted in the presence of a substoichiometric amount of 
micro-particles of magnetite (65% of the stoichiometric gram 
ART ICLE  INFO  AB ST R ACT  
Article history: 
Received 
Received in revised form 
Accepted 
Available online 
In memory of Prof. Robert E. Gawley 
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atomic mass of iron) gave a mixture of isomers (Z)-3a and (E)-4a 
after only 15 min at 70 ºC (entry 2). Both isomers could be 
isolated by column chromatography and fully characterized. 
Once the activity of unmodified commercial magnetite was 
proved, the size of the particles was tested, finding that the 
related nano-particle gave even better yield and Z/E ratio (3.8/1, 
entry 3). Then, the influence of the amount of catalyst was 
studied (entries 3-6), as well as the temperature (entries 6-8), the 
reagent’s ratios (entries 9 and 10), and the solvent (entries 11-
16), with the best condition being described in the entry 4. 
 
Table 1  
Optimization of the reaction conditionsa 
 
Entry Cat. (mol%) T (º C) Solvent t (h) 3a (%)b 4a (%)b 
1  70 PhMe 7 0 0 
2 Fe3O4
c (65) 70 PhMe 0.25 62 20 
3 Fe3O4
d (65) 70 PhMe 0.25 72 19 
4 Fe3O4
d(33) 70 PhMe 0.25 83 11 
5 Fe3O4
d (13) 70 PhMe 0.25 64 18 
6 Fe3O4
d (130) 70 PhMe 0.25 66 16 
7 Fe3O4
d (33) 110 PhMe 0.25 55 22 
8 Fe3O4
d (33) 25 PhMe 7 44 23 
9e Fe3O4
d (33) 70 PhMe 0.25 73 21 
10f Fe3O4
d (33) 70 PhMe 0.25 59 13 
11 Fe3O4
d (33) 70 - 0.25 61 21 
12 Fe3O4
d (33) 70 Dioxane 0.25 0 0 
13 Fe3O4
d (33) 70 MeCN 0.25 0 0 
14 Fe3O4
d (33) 70 DMF 0.25 0 0 
15 Fe3O4
d (33) 70 CHCl3 0.25 61 28 
16 Fe3O4
d (33) 70 (ClCH2)2 0.25 60 30 
17 FeO (33) 70 PhMe 1 24 8 
18 Fe2O3 (33) 70 PhMe 0.25 74 21 
19 FeCl2 (33) 70 PhMe 1 20 8 
20 FeCl3 (33) 70 PhMe 0.25 69 24 
a Reaction carried out using 1a (1.5 mmol) and 2a (1.0 mmol) in the 
corresponding solvent (2.5 mL) under an argon atmosphere. b Isolated yield 
after column chromatography. c Powder < 5 m. d Powder < 50 nm. e 
Reaction performed using 1a (2 mmol) and 2a (1.0 mmol). f Reaction 
performed using 1a (1.0 mmol) and 2a (2.0 mmol). 
 
After finding the activity of nano-particles of magnetite, we 
studied the activity of other iron sources, such as iron(II) and (III) 
as catalyst (entries 17 and 18), with nano-particles of Fe2O3 
having a similar activity to magnetite. The necessity of a slight 
excess of acyl chloride to complete the reaction made us suspect 
that the magnetite function was to form a soluble iron chloride 
species, and to prove this fact we performed the reaction using 
FeCl2 and FeCl3, and, as in the case of oxides, the iron(III) salt 
gave a better result than iron(II). However, the results were 
significantly inferior to that obtained using magnetite (compare 
entries 4, 19 and 20), and with the price of iron chloride being 
also another small disadvantage. It should be pointed out that the 
recycled magnetite had a lower activity rendering, in a second 
trial, a mixture of compounds in lower yield (72 %), and 
dropping to 47 % in the third run. To understand this fact, we 
studied by ICP-MS analysis the resulting reaction solution 
mixture after the first cycle, finding that 1.1% of initial amount 
of iron of the catalyst was leached to the solution. This leaching 
phenomenon could explain the decrease of the obtained yield.  
Recently, we have developed a new, simple, and robust 
method to immobilize different transition metal oxides onto 
micro-particles of magnetite,
12
 and we studied these catalysts, as 
well as new ones such as rhodium, silver, tungsten, and gold 
derivatives (see supporting information) as possible promoters of 
the process. However, in all cases the results (Table 2) were 
similar to those obtained using only the magnetite support (entry 
1). 
 
Table 2  
Optimization of the catalysta 
 
Entry Catalyst (mol%) 3a (%)b 4a (%)b 
1 Fe3O4
[c] (65) 62 20 
2 CoO-Fe3O4 (1.4) 56 18 
3 NiO-Fe3O4 (1.4) 58 29 
4 CuO-Fe3O4 (1.3) 64 24 
5 Ru2O3-Fe3O4 (1.4) 64 23 
6 Rh2O3-Fe3O4 (0.8) 58 26 
7 PdO-Fe3O4 (1.4) 8 4 
8 Ag2O/Ag-Fe3O4 (1.3) 66 20 
9 WO3-Fe3O4 (0.6) 66 16 
10 IrO2-Fe3O4 (0.14) 67 19 
11 PtO/PtO2-Fe3O4 (0.6) 59 17 
12 Au2O3/Au-Fe3O4 (0.1) 65 21 
13 NiO/CuO-Fe3O4 (0.9/1.1) 60 25 
14 PdO/CuO-Fe3O4 (1.5/0.8) 9 6 
a Reaction carried out using 1a (1.5 mmol) and 2a (1.0 mmol) in toluene (2.5 
mL) under an argon atmosphere. b Isolated yield after column 
chromatography. c Powder < 5 m. 
 
As the nano-particle of magnetite was the best catalyst, the 
scope of the reaction was studied (Table 3). The reaction gave the 
expected Z-isomers 3 as the main product after only a 1 h 
reaction. The reaction gave similar results independently of the 
side chain of internal alkyne (entries 1-3). In the case of using 
ethynylbenzene (entry 4) practically only one regio- and stereo-
isomer was obtained, as it was previously found for other 
ruthenium, iridium or iron complexes. The presence of electron-
withdrawing or electron-donating groups at the para-position of 
aromatic ring did not have a significant effect on the results 
(entries 5-7). However, the presence of a group located at ortho-
position (entry 8) of the acid chloride gave worse results, in terms 
of chemical yield and isomeric ratio. This fact could be a proof of 
a possible steric hindrance in the transition state. Other acyl 
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derivatives, such as 4-naphthyl or thienyl, were used without 
finding any difference with the model reagents (compare entries 
1, 9 and 10). The reaction of 4-methoxybenzoyl chloride with 
1,2-diphenylethyne gave the expected product 3k (entry 11). It 
should be pointed out that the reaction using aliphatic 3-
phenylpropanoyl chloride gave the expected mixture of products 
(Z)-3l and (E)-4l, with the main isomer 3l not being possible to 
be separated from the isomer 4l; contrary to other aromatic 
examples, in which isomer 3 could be isolated but not the related 
4. 
 
Table 3  
Preparation of -chlorovinyl ketonesa 
 
Entry R1 R2 R3 Z/E ratiob No. Yield (%)c 
1 Ph nBu nBu 7.5/1 3a 83 
2 Ph Et Et 7.5/1 3b 89 
3 Ph nC5H11 nC5H11 5.7/1 3c 82 
4 Ph H Ph >20/1 3d 63 
5 4-ClC6H4 nBu nBu 3.5/1 3e 70 
6 4-tBuC6H4 nBu nBu 3.5/1 3f 75 
7 4-MeOC6H4 nBu nBu 15/1 3g 91
d 
8 2-MeOC6H4 nBu nBu 2.2/1 3h 58 
9 4-FC10H6
e nBu nBu 15/1 3i 89 
10 2-Thienyl nBu nBu 4.1/1 3j 74 
11 4-MeOC6H4 Ph Ph 4/1 3k 72 
12 Ph(CH2)2 nBu nBu 3/1 3l
f 77 
a Reaction carried out using 1 (1.5 mmol) and 2 (1.0 mmol) in toluene (2.5 
mL) under an argon atmosphere. b Determined by 1H NMR from the 
crude mixture. c Isolated yield after column chromatography. d The relate 
indenone derivative was detected from the crude reaction medium by GC-
MS (< 3%). e 4-FC10H6 denotes for 4-fluoronaphth-1-yl. 
f The compound 
3l could not be separated from the mixture of both isomers (Z)-3l/(E)-3l. 
 
The above protocol could be used not only for acyl chlorides 
(1) but also for the related bromides. Thus, the addition of 
benzoyl bromide (5) to dec-5-yne (2a) using nano-particles of 
magnetite (Scheme 1) gave the expected bromovinyl ketone 6, 
with similar yield and isomeric ratio to the case of using the 
related chlorine reagent.  
 
 
Scheme 1 Preparation of a -bromovinyl ketone. 
 
2.2. Nazarov-type Cyclization Processes 
The mechanistic considerations of this reaction have proposed 
the formation of a vinyl cation
3c,4,5,10
 intermediate which is 
captured by the chloride ion through an intra- or intermolecular 
process. With this proposed catalytic mechanism in mind, we 
thought that the cationic intermediate could be trapped to form a 
cyclic compound by using the adequate olefinic reagent in a 
Nazarov-type process.
13 
So, the reaction of the alkyne 2a with 
cinnamoyl chloride (7a, X = H) yielded, after only one hour at 70 
ºC, the expected 5-chlorocyclopent-2-enone 8a in good yield and 
as a single isomer (Table 4, entry 1). 
 
Table 4  
Preparation of 5-chloro-4-arylcyclopent-2-enonesa 
 
Entry Catalyst X R1 R2 No. Yield (%)b 
1 Fe3O4
c,d H nBu nBu 8a 78 
2 Fe3O4
c H nBu nBu 8a 77 
3 Fe3O4
c,e H nBu nBu 8a 58 
4 FeO H nBu nBu 8a 29 
5 Fe2O3 H nBu nBu 8a 67 
6 FeCl2 H nBu nBu 8a 34 
7 FeCl3 H nBu nBu 8a 69 
8 Fe3O4
c H Et Et 8b 89 
9 Fe3O4
c H nC5H11 nC5H11 8c 91 
10 Fe3O4
c H Me tBu 8d 91f 
11 Fe3O4
c F nBu nBu 8e 67 
12 Fe3O4
c MeO nBu nBu 8f 83 
a Reaction carried out using 7 (1.5 mmol) and 2 (1.0 mmol) in toluene (2.5 
mL) under an argon atmosphere. b Isolated yield after column 
chromatography. c Power < 50 nm. d Reaction performed using 33 mol%. 
[e] Reaction performed using 7 mol%. f Mixture of isolated isomers (cis-
8d/trans-8d’: 3/88 %). 
 
Then, we studied the influence of the amount of nano-
magnetite (entries 1-3), the source of iron oxides (entries 4 and 
5), and different iron chlorides (entries 6 and 7). As in the case of 
the chlorovinylation process, nano-magnetite gave even better 
results than iron(III) oxide or chloride. The reaction was 
performed with similar results with other symmetrically 
substituted alkynes (entries 8 and 9). In the case of using 4,4-
dimethylpent-2-yne (2f), the reaction was regioselective, 
rendering only the corresponding 2-methyl-3-tert-
butylcyclopentenone 8d with good yield (entry 10). However, 
only in this case both diastereomeric cis/trans isomer were 
detected and isolated. The assignation of relative configuration 
was performed in basis of the constant coupling between both 
hydrogen of cyclopentenone ring. The minor isomer showed a J 
= 2.8 Hz, and it was assumed that it was the cis-8d. Meanwhile 
the major isomer showed a J = 1.0 Hz, and it was assumed that it 
was the trans-8d’. These constant coupling for all compounds 8 
were always higher than 2.5 Hz and they were assigned as cis-
ones. The reaction using a para-substituted cinnamoyl chloride 
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gave the expected product 8 with similar results to previous 
trials, independently of the electron-nature of the group (entries 
11 and 12). 
After the success in the cyclization process, we rationalized 
that the stabilization of the vinyl-cation intermediate could give 
us a chance to carry out an intramolecular aromatic electrophilic 
substitution, yielding fused bicyclic ketones.
3c,7a
 For this purpose, 
we carried out the model reaction of 2-naphthalenecarbonyl 
chloride (1j) with the unsymmetrical 1-phenylpentyne (9a) and, 
after only one hour, the corresponding 3-phenyl-2-methyl-1H-
cyclopenta[a]naphthalen-1-one (10a) was obtained in excellent 
yield and regioselectivity (entry 1 in Table 5), with the other 
regioisomer not being detected. The structure of compounds 10 
was unambiguously assigned according to NOESY, HSQC- and 
HMBC-NMR experiments, as well as X-ray data for compound 
10a (see Figure 1). The reaction with other 1-arylalkynes gave, in 
all cases, the corresponding products 10 (entries 2 and 3) with the 
reaction pathway starting with the regioselective addition of acyl 
cation to form the most stable 1-arylvinyl cation.  
 
Table 5  
Preparation of 3-aryl-1H-cyclopenta[a]naphthalen-1-onesa 
 
Entry Ar R No. 4a (%)b 
1 Ph Me 10a 91 
2 Ph nBu 10b 87 
3 4-MeC6H4 Me 10c 79 
a Reaction carried out using 1j (1.5 mmol) and 9 (1.0 mmol) in toluene (2.5 
mL) under an argon atmosphere. b Isolated yield after column 
chromatography. 
 
 
Figure 1 ORTEP drawing of compound 10a. 
 
Then, we tried to extend the scope of the reaction to simple 
alkynes of type 2, in which the postulated cationic intermediate is 
less stable. The reaction between the acid chloride 1j and hex-3-
yne (2b) did not produce the expected cyclopenta[a]naphthlen-1-
ones of type 10, but yielded the product 11a (Table 6, entry 1) 
with a good chemical yield. To the best of our knowledge, this 
type of compound has been synthesized for the first time, and its 
formation could be explained by a simple isomerization, in the 
reaction media, from the α,β-unsaturated ketone of type 10 to the 
corresponding conjugated stryryl unit 11. We do not have any 
clear explanation of the driving force for this process. The 
structure of compound 11 was unambiguously assigned 
according to NOESY, HSQC- and HMBC-NMR experiments, as 
well as X-ray data for compound 11a (see Figure 2). The reaction 
seems to be general, obtaining similar results for all tested 
aliphatic-substituted internal alkynes (entries 2 and 3). 
 
Table 6  
Preparation of (E)-3-alkylidene-2,3-dihydro-1H-cyclopenta[a]naphthalen-1-
onesa 
 
Entry R No. Yield (%)b 
1 Me 11a 85 
2 nPr 11b 87c,d 
3 nBu 11c 84 
a Reaction carried out using 1j (1.5 mmol) and 2 (1.0 mmol) in toluene (2.5 
mL) under an argon atmosphere. b Isolated yield after column 
chromatography. c Reaction performed during 4 h. d A 5 % of chlorovinyl 
ketone of type 3m was isolated. 
 
 
Figure 2 ORTEP drawing of compound 11a. 
 
To avoid the formation of an exo-cyclic double bond in 
compounds 11, we repeated the reaction with alkyne 2f (Scheme 
2). However, in this case, a 1,2-shift methyl migration took place, 
after the vinyl-cation formation to give the more stable allylic 
intermediate, which, then cyclized to yield compound 12. This 
behavior was previously described for other Lewis acid 
catalysts.
3c,14
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Scheme 2 Preparation of compound 12. 
 
The hypothetic mechanism pathway is depicted in Scheme 3. 
The adsorption of acyl chloride on the surface of the magnetite 
with a debilitation of the corresponding chlorine carbon bond in 
A is the first step of the process. The addition to the alkyne 
reagent would generate the key vinyl cation C. This intermediate 
C renders different intermediates depending on the nature of the 
substituent R
1
 of the starting acyl chloride. So, the usual pathway 
was the reaction with chloride in a syn-manner (D). However, if 
the R
1
 group has a carbon-carbon double bond (R
1
 = ArCH=CH) 
the vinyl cation C suffers a cyclization process to give 
intermediate E, or if the R
1
 group has the possibility of suffering 
electrophilic aromatic substitution (R
1
 = 1-naphthyl) the 
intermediate yielded cation F.  
 
 
Scheme 3 Proposed mechanism for the addition of acid chloride to alkynes 
and further evolution. 
 
2.3. Furan Cyclization 
Very recently, the Tsuji research group has found a new entry 
to the direct synthesis of 2,5-disubstituted furans starting from 
acid chlorides and terminal alkynes, in moderate yields for 
phenyl derivatives and low yields for thienyl ones.
8a
 The possible 
catalytic pathway involved the dehydrochlorination of the 
corresponding chlorovinyl ketone followed by cyclization of 
formed allenic ketone. Since zinc chloride, in combination with 
an amine, has been introduced as a catalyst for this elimination 
process,
15
 we studied the activity of other Lewis acid catalysts for 
this tandem dehydrochlorination-cyclization process (Table 7), 
with the idea in mind to integrate all processes starting from 
internal alkynes to yield 1,2,5-trisubstituted furans. 
The reaction of chlorovinyl ketone 3a with nano-power 
magnetite did not yield the expected furan 13a after 7 days at 130 
ºC. However, the same process but using rhodium trichloride 
gave the product 13a in a moderate yield. Then other transition 
salts were tested, with palladium and iridium giving excellent 
results (entries 3 and 4). Finally, the same process was conducted 
with the related transition metal oxides impregnated on magnetite 
(entries 5-7). From the comparison of the results from both types 
of catalysts could be concluded that the heterogeneous catalysts 
gave better results than homogenous ones, since with amounts 
around 1 mol% of heterogeneous catalysts it was possible to 
obtain similar results to the reached using homogeneous ones at 
10 mol% loading.  
 
Table 7  
Cyclization of -chlorovinyl ketone 3aa 
 
Entry Catalyst (mol%) Yield 13a (%)[b] 
1 Fe3O4
[c] (65) 0 
2 RhCl3 (10) 54 
3 PdCl2 (10) 89 
4 IrCl3 (10) 87 
5 Rh2O3-Fe3O4 (0.8) 75 
6 PdO-Fe3O4 (1.4) 82 
7 IrO2-Fe3O4 (0.07) 95 
a Reaction carried out using 3a (1 mmol) in toluene (2.5 mL) under an argon 
atmosphere. b Isolated yield after column chromatography. c Powder < 5 m. 
 
Once we found that the dehydrochlorination-cyclization 
process was catalyzed by different metallic oxides impregnated 
on magnetite (Table 7) and that the magnetite could catalyze the 
addition of acid chlorides to internal alkynes, we tried to perform 
the whole integrated process. The reaction of chloride 1a with the 
alkyne 2a gave the expected product 13a after seven days at 130 
ºC. However, the chemical yield was moderate, independently of 
the catalyst used (Scheme 4). Then, we carried out the reaction 
with IrO2-Fe3O4 at 70 ºC during 1 h (chloroacylation process) 
and, after that, the temperature was increased up to 130 ºC, with 
the yield of compound 13a and 3a being 59 and 30 %, 
respectively.  
 
 
Scheme 4 Direct Synthesis of Furan 13a. 
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We believed that the main reason for this behavior was that 
the excess of acid chloride decomposed the catalyst, and formed 
the corresponding less active and soluble transition metal 
chloride. To prove this hypothesis we perform a two step one-pot 
process (Table 8). After carrying out the standard reaction of 
chloride 1a with alkyne 2a catalyzed by nano-powder magnetite, 
this catalyst was removed by a magnet and RhCl3 (1 mol%, entry 
1), PdCl2 (1 mol%, entry 2), or IrCl3 (1 mol%, entry 3) was added 
to this mixture giving in all cases better results than the strategy 
showed in Scheme 3. Instead of homogenous salt, we, then, 
studied the same process but using the impregnated catalyst. 
After removing the magnetite by the magnet, the corresponding 
palladium impregnated on magnetite catalyst was added (1.2 
mol%, entry 4) obtaining a similar result to the obtained one 
using the homogenous catalyst. The protocol using iridium 
impregnated catalyst (0.07 mol%) gave an excellent result (entry 
5, 88%) , since the same reaction but using IrCl3 (0.07 mol%) 
yielded 43% of compound 13a. Then, the scope of the reaction 
using IrO2-Fe3O4 was tested finding that the length of the alkyne 
side chain did not influence the result (entry 6). Even, quite 
similar results were obtained independently of the presence of 
electron–withdrawing or –donating groups in the ring of acyl 
chloride (entries 7 and 8). Finally, it should be pointed out that 
the protocol rendered similar result in the special case of the 
thienyl derivative (entry 9), which was a challenging example for 
the construction of more simple 2,5-disubstituted furans.
8a
 
 
Table 8  
One-pot Synthesis of 1-Aryl-2,4-dialkylfuransa 
 
Entry Ar R No. Yield (%)b 
1 Ph nPr 13a 62
c,d 
2 Ph nPr 13a 87c,e 
3 Ph nPr 13a 90c,f 
4 Ph nPr 13a 70g 
5 Ph nPr 13a 88 (51) 
6 Ph Me 13b 91 (68) 
7 4-ClC6H4 nPr 13c 76 (55) 
8 4-MeOC6H4 nPr 13d 94 (69) 
9 2-Thienyl nPr 13e 74 (41) 
a Reaction carried out using 1 (1.5 mmol) and 2 (1.0 mmol) in toluene (2.5 
mL) under an argon atmosphere. b Isolated yield after column 
chromatography; In the parenthesis appear the results using Rh2O3-Fe3O4 
(0.8 mol%) as catalyst for the step ii. c Reaction performed during 7 d. d In 
the step ii, only RhCl3 (1 mol%) was used as catalyst. 
e In the step ii, only 
PdCl2 (1 mol%) was used as catalyst. 
f In the step ii, only IrCl3 (1 mol%) 
was used as catalyst. g In the step ii, only PdO-Fe3O4 (1.2 mol%) was used as 
catalyst. 
 
3. Conclusion 
In conclusion, we have demonstrated that simple and 
commercially available magnetite is a good catalyst for the 
chloroacylation of internal alkynes, as well as terminal ones, 
yielding the corresponding chlorovinyl ketones with good yields. 
The process could be applied to the synthesis of 5-chloro-4-
arylcyclopent-2-enones, 3-aryl-1H-cyclopenta[a]naphthalen-1-
ones, and (E)-3-alkylidene-2,3-dihydro-1H-
cyclopenta[a]naphthalen-1-ones, just by changing either the 
starting acyl chloride or alkyne. The acceptable to excellent 
regio- and steroselectivity of the process, together with the low 
price of catalyst and the simplicity of the process could anticipate 
a good future for the process shown in this study not only in the 
laboratory but also in industry. Moreover, the use of iridium 
impregnated on magnetite into an integrated process allowed us 
the one-pot synthesis of 1-aryl-2,4-dialkylfurans with good 
yields, independently of the nature of the starting regents, 
including heteroaromatic ones, with the low catalyst loading 
being an important issue. 
 
4. Experimental section 
4.1. General information 
XPS analyses were carried out on a VG-Microtech Mutilab. 
TEM images were obtained on a JEOL, model JEM-2010 
equipped with an X-ray detector OXFORD INCA Energy TEM 
100 for microanalysis (EDS). XRF analyses were obtained on a 
PHILIPS MAGIX PRO (PW2400) X-ray spectrometer equipped 
with a rhodium X-ray tube and a beryllium window. BET 
isotherms were carried out on a AUTOSORB-6 (Quantachrome), 
using N2. Melting points were obtained with a Reichert 
Thermovar apparatus. NMR spectra were recorded on a Bruker 
AC-300 (300 MHz for 
1
H and 75 MHz for 
13
C) using CDCl3 as a 
solvent and TMS as internal standard for 
1
H and 
13
C; chemical 
shifts are given in δ (parts per million) and coupling constants (J) 
in Hertz. FT-IR spectra were obtained on a JASCO 4100LE (Pike 
Miracle ATR) spectrophotometer. Mass spectra (EI) were 
obtained at 70 eV on a Himazdu QP-5000 spectrometer, giving 
fragment ions in m/z with relative intensities (%) in parentheses. 
HRMS spectra were obtained with a Finnigan High-resolution 
Mass Spectrometer (MAT95S model). Single-Crystal XRD 
analyses were obtained on a Bruker CCD-Apex equipped with a 
X-ray tube with Mo anode. Crystallographic data for compounds 
10a (CCDC 910476) and 11a (CCDC 910475) can be obtained 
free of charge from Cambridge Crystallographic Data Centre. 
Thin layer chromatography (TLC) was carried out on Schleicher 
& Schuell F1400/LS 254 plates coated with a 0.2 mm layer of 
silica gel; detection by UV254 light, staining with 
phosphomolybdic acid [25 g phosphomolybdic acid, 10 g 
Ce(SO4)2 4 H2O, 60 mL of concentrated H2SO4 and 940 mL 
H2O]. Column chromatography was performed using silica gel 60 
of 35-70 mesh. All reagents were commercially available (Acros, 
Aldrich, Fluorochem) and were used as received. 
 
4.2. General procedure for the preparation of catalysts 
To a stirred solution of the corresponding metal salt MClx (1 
mmol) in deionized water (150 mL) was added commercial 
available Fe3O4 (4 g, 17 mmol, powder < 5 µm, BET area: 9.86 
m
2
/g). After 10 minutes at room temperature, the mixture was 
slowly basified with NaOH (1M) until pH around 13. The 
mixture was stirred during one day at room temperature in air. 
After that, the catalyst was filtered and washed several times with 
deionized water (3 × 10 mL). The solid was dried at 100 ºC 
during 24 h in a standard glassware oven obtaining the expected 
catalyst. The rhodium catalyst gave an incorporation of rhodium 
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of 1.7 % according to XRF; by XPS the rhodium on the surface 
was determined as 17.5 %; the BET area surface was 8.4 m
2
/g. 
The silver catalyst gave an incorporation of silver of 2.7 % 
according to XRF; by XPS the silver on the surface was 
determined as 6.2 %; the BET area surface was 7.4 m
2
/g. The 
tungsten catalyst gave an incorporation of tungsten of 2.1 % 
according to XRF; by XPS the tungsten on the surface was 
determined as 13.6%; the BET area surface was 7.7 m
2
/g. The 
gold catalyst gave an incorporation of gold of 1.5 % according to 
XRF; by XPS the gold on the surface was determined as 14.8 %; 
the BET area surface was 7.9 m
2
/g. 
 
4.3. General procedure for the addition reactions 
To a stirred solution of alkyne (2 or 9, 1 mmol) in dry toluene 
(2.5 mL) under argon atmosphere were added Fe3O4 (25 mg or 10 
mg) and the corresponding acid derivative (1, 5 or 7, 1.5 mmol). 
The resulting mixture was stirred at 70 ºC during one hour. The 
catalyst was removed by a magnet and the resulting mixture was 
quenched with water (5 mL) and extracted with EtOAc (3 × 5 
mL). The organic phases were dried over MgSO4, followed by 
evaporation under reduced pressure to remove the solvent. The 
product was usually purified by chromatography on silica gel 
(hexane/ethyl acetate) to give the corresponding products 3, 4, 6, 
8, 10, 11 and 12. Physical and spectroscopic data, as well as 
literature for known compounds, follow: 
 
4.3.1. (Z)-2-Butyl-3-chloro-1-phenylhept-2-en-1-one (3a): 
brown oil; Rf = 0.77 (hexane/ethyl acetate 4:1); tr 14.3; IR (cm
-1
): 
1668, 1637, 1596, 1579, 1465, 1448, 1313, 1268, 1212, 935, 719, 
689;
 1
H-NMR (300 MHz, CDCl3):  0.77 (t, J = 7.3 Hz, 3H, 
ClCCH2CH2CH2CH3), 0.86 (t, J = 7.1 Hz, 3H, 
ClCCCH2CH2CH2CH3), 1.1-1.2, 1.25-1.45, 1.45-1.55, (3m, 2, 4 
and 2H, respectively, CH2 × 4), 2.18 (t, J = 7.3 Hz, 2H, ClCCH2), 
2.5 (t, J = 7.1 Hz, 2H, ClCCCH2), 7.4-7.5 (m, 2H, OCCCHCH × 
2), 7.55-7.65 (m, 1H, OCCCHCHCH), 7.85-7.95 (m, 2H, 
OCCCH × 2);
 13
C-NMR (75 MHz, CDCl3):  13.7, 13.7, 21.7, 
22.5, 29.6, 29.7, 32.3, 36.9, 128.7 (2C), 129.4 (2C), 133.6, 136.4, 
137, 137.1, 197.5; EI-MS m/z: 278 (M
+
, 10 %), 243 (25), 237 
(10), 235 (28), 187 (10), 179 (23), 145 (11), 105 (100), 77 (46). 
HRMS calcd. for C17H23ClO: 278.1437; found: 278.1434. 
 
4.3.2. (Z)-3-Chloro-2-ethyl-1-phenylpent-2-en-1-one (3b):
10
 
yellow oil, Rf = 0.7 (hexane/ethyl acetate 4:1); tr 12.4;
 
IR (cm
-1
): 
1666, 1638, 1596, 1449, 1285, 1242, 822, 711, 689; 
1
H-NMR 
(300 MHz, CDCl3):  1.03 (t, J = 7.6 Hz, 3H, ClCCCH2CH3), 
1.04 (t, J = 7.3 Hz, 3H, ClCCH2CH3), 2.2 (q, J = 7.3 Hz, 2H, 
ClCCH2), 2.53 (q, J = 7.6 Hz, 2H, ClCCCH2), 7.45-7.5 (m, 2H, 
OCCCHCH × 2), 7.55-7.65 (m, 1H, OCCCHCHCH), 7.85-7.95 
(m, 2H, OCCCH × 2);
 13
C-NMR (75 MHz, CDCl3):  11.8, 12.3, 
25.7, 30.6, 128.7 (2C), 129.3 (2C), 133.6, 136.4, 137.3, 137.4, 
197.3; EI-MS m/z: 222 (M
+
, 10 %), 187 (59), 159 (32), 158 (13), 
105 (100), 77 (67). 
 
4.3.3. (Z)-3-Chloro-2-pentyl-1-phenyloct-2-en-1-one (3c): 
yellow oil; Rf = 0.73 (hexane/ethyl acetate 4:1); tr 15.5; IR (cm
-1
): 
1669, 1596, 1465, 1448, 1314, 1259, 719, 689; 
1
H-NMR (300 
MHz, CDCl3):  0.79, 0.84 (2t, J = 7.1 and 7 Hz, respectively, 3H 
each one, CH3 × 2), 1.05-1.2, 1.2-1.35, 1.35-1.6, (3m, 4H each 
one, CH2 × 6), 2.18 (t, J = 7.3 Hz, 2H, ClCCH2), 2.49 (t, J = 7.6 
Hz, 2H, ClCCCH2), 7.4-7.5 (m, 2H, OCCCHCH × 2), 7.55-7.65 
(m, 1H, OCCCHCHCH), 7.85-7.95 (m, 2H, OCCCH × 2);
 13
C-
NMR (75 MHz, CDCl3):  13.8, 13.9, 22.2, 22.3, 27.1, 27.3, 
30.8, 31.5, 32.6, 37.1, 128.7 (2C), 129.4 (2C), 133.6, 136.4, 137, 
137.1, 197.4; EI-MS m/z: 270 (7 %), 227 (14), 105 (100), 77 
(34). HRMS calcd. for C19H27ClO-HCl: 270.1984; found: 
270.1995. 
 
4.3.4. (Z)-3-Chloro-1,3-diphenylprop-2-en-1-one (3d):
10
 
pale yellow oil; Rf = 0.37 (hexane/ethyl acetate 4:1); tr 16.3; IR 
(cm
-1
): 1662, 1597, 1574, 1446, 1234, 1206, 1016, 756, 687; 
1
H-
NMR (300 MHz, CDCl3):  7.35 (s, 1H, ClCCH), 7.4-7.5, 7.55-
7.6, 7.7-7.8, 7.95-8.05 (4m, 5, 1, 2 and 2H, respectively, Ph × 2);
 
13
C-NMR (75 MHz, CDCl3):  121.4, 127.1 (2C), 128.6 (2C), 
128.6 (2C), 128.7 (2C), 130.5, 133.3, 137.3, 137.7, 143.3, 189.8; 
EI-MS m/z: 244 (M
+
+2, 15 %), 243 (M
+
+1, 39), 242 (M
+
, 46), 
241 (100), 179 (18), 178 (19), 167 (10), 165 (31), 105 (61), 102 
(58), 101 (17), 89 (16), 77 (96). 
 
4.3.5. (Z)-2-Butyl-3-chloro-1-(4-chlorophenyl)hept-2-en-1-
one (3e): yellow oil; Rf = 0.73 (hexane/ethyl acetate 4:1); tr 15.6; 
IR (cm
-1
): 1670, 1586, 1465, 1399, 1266, 1211, 1091, 1013, 932, 
846, 771, 757; 
1
H-NMR (300 MHz, CDCl3):  0.8, 0.88 (2t, J = 
7.3 and 7.1 Hz, respectively, 3H each one, CH3 × 2), 1.1-1.25, 
1.3-1.45, 1.45-1.55 (3m, 2, 4 and 2H, respectively, CH2 × 4), 
2.19 (t, J = 7.4 Hz, 2H, ClCCH2), 2.5 (t, J = 7.2 Hz, 2H, 
ClCCCH2), 7.48 (d, J = 8.5 Hz, 2H, ClCCH × 2), 7.86 (d, J = 8.5 
Hz, 2H, ClCCHCH × 2),;
 13
C-NMR (75 MHz, CDCl3):  13.7, 
13.7, 21.7, 22.5, 29.6, 29.7, 32.3, 37, 129.2 (2C), 130.8 (2C), 
134.7, 136.7, 137.3, 140.2, 196.2; EI-MS m/z: 277 (11 %), 141 
(34), 140 (9), 139 (100), 111 (27). HRMS calcd. for C17H22Cl2O-
Cl: 277.1359; found: 277.1340. 
 
4.3.6. (Z)-2-Butyl-1-(4-[tert-butyl]phenyl)-3-chlorohept-2-
en-1-one (3f): yellow oil;  Rf = 0.77 (hexane/ethyl acetate 4:1); tr 
16.4; IR (cm
-1
): 1667, 1603, 1463, 1268, 1188, 1107, 933, 852, 
780, 719; 
1
H-NMR (300 MHz, CDCl3):  0.77, 0.87 (2t, J = 7.3 
and 7.1 Hz, respectively, 3H each one, CH3 × 2), 1.1-1.2, 1.25-
1.45, 1.45-1.6 (3m with s at 1.36, 9, 2, 4 and 2H, respectively, 
CH2 × 4 and C(CH3)3), 2.19 (t, J = 7.3 Hz, 2H, ClCCH2), 2.51 (t, 
J = 7.1 Hz, 2H, ClCCCH2), 7.5 (d, J = 8.5 Hz, 2H, OCCCHCH × 
2), 7.84 (d, J = 8.5 Hz, 2H, OCCCH × 2);
 13
C-NMR (75 MHz, 
CDCl3):  13.6, 13.7, 21.7, 22.5, 29.6, 29.7, 31 (3C), 32.3, 35.2, 
36.9, 125.7 (2C), 129.4 (2C), 133.8, 136.4, 137.2, 157.5, 197.1; 
EI-MS m/z: 298 (12 %), 283 (11), 269 (12), 162 (12), 161 (100). 
HRMS calcd. for C21H31ClO-HCl: 298.2297; found: 298.2312. 
 
4.3.7.  (Z)-2-Butyl-3-chloro-1-(4-methoxyphenyl)hept-2-en-
1-one (3g): yellow oil; Rf = 0.43 (hexane/ethyl acetate 4:1); tr 
16.2; IR (cm
-1
): 1659, 1597, 1255, 1215, 1159, 1030, 845; 
1
H-
NMR (300 MHz, CDCl3):  0.73, 0.82 (2t, J = 7.3 and 7.1 Hz, 
respectively, 3H each one, CH3 × 2), 1.05-1.2, 1.2-1.35, 1.35-1.5 
(3m, 2, 4 and 2H, respectively, CH2 × 4), 2.15 (t, J = 7.4 Hz, 2H, 
ClCCH2), 2.45 (t, J = 7.1 Hz, 2H, ClCCCH2), 3.84 (s, 3H, 
OCH3), 6.92 (d, J = 8.8 Hz, 2H, OCCCHCH × 2), 7.84 (d, J = 8.8 
Hz, 2H, OCCCH × 2);
 13
C-NMR (75 MHz, CDCl3):  13.6, 13.6, 
21.6, 22.4, 29.5, 29.6, 32.3, 36.8, 55.3, 113.9 (2C), 129.2, 131.7 
(2C), 135.7, 137, 163.9, 195.8; EI-MS m/z: 272 (9 %), 243 (10), 
135 (100), 77 (10). HRMS calcd. for C18H25ClO2-HCl: 272.1776; 
found: 272.1780. 
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4.3.8.  (Z)-2-Butyl-3-chloro-1-(2-methoxyphenyl)hept-2-en-
1-one (3h): pale yellow oil; Rf = 0.47 (hexane/ethyl acetate 4:1); 
tr 15.1; IR (cm
-1
): 1656, 1597, 1484, 1463, 1435, 1288, 1246, 
1162, 1024, 931, 754; 
1
H-NMR (300 MHz, CDCl3):  0.81, 0.86 
(2t, J = 7.3 and 7.2 Hz, respectively, 3H each one, CH3 × 2), 
1.15-1.25, 1.25-1.35, 1.35-1.45, 1.45-1.55 (4m, 2H each one, 
CH2 × 4), 2.35 (t, J = 7.5 Hz, 2H, ClCCH2), 2.46 (t, J = 7.5 Hz, 
2H, ClCCCH2), 3.86 (s, 3H, OCH3), 6.96 (d, J = 8.3 Hz, 1H, 
CH3OCCH), 7.02 (td, J = 7.6 Hz, 
4
J = 0.7 Hz, 1H, 
CH3OCCCHCH), 7.49 (td, J = 8.2, Hz, 
4
J = 1.7 Hz, 1H, 
CH3OCCHCH), 7.62 (dd, J = 7.6 Hz, 
4
J = 1.7 Hz, 1H, 
CH3OCCCH);
 13
C-NMR (75 MHz, CDCl3):  13.7, 13.8, 21.9, 
22.5, 29.7, 29.9, 31.8, 36.6, 55.6, 111.7, 120.5, 127.9, 131.1, 
133.8, 139.5, 139.8, 158.6, 196.5; EI-MS m/z: 308 (M
+
, 0.1 %), 
135 (100), 77 (12). HRMS calcd. for C18H25ClO2: 308.1543; 
found: 308.1515. 
 
4.3.9.  (Z)-2-Butyl-3-chloro-1-(4-fluoronaphthalen-1-
yl)hept-2-en-1-one (3i): orange oil; Rf = 0.77 (hexane/ethyl 
acetate 4:1); tr 18.3; IR (cm
-1
): 1661, 1627, 1599, 1463, 1424, 
1243, 1214, 1050, 769; 
1
H-NMR (300 MHz, CDCl3):  0.76, 0.89 
(2t, J = 7.3 and 7.2 Hz, respectively, 3H each one, CH3 × 2), 1.1-
1.25, 1.3-1.4, 1.45-1.6 (3m, 2, 2 and 4H, respectively, CH2 × 4), 
2.30 (t, J = 7.4 Hz, 2H, ClCCH2), 2.58 (t, J = 7.6 Hz, 2H, 
ClCCCH2), 7.19 (dd, 
3
J(H,F) = 9.6 Hz, J = 8.3 Hz, 1H, FCCH), 
7.6-7.7 (m, 1H, FCCCHCH), 7.73 (ddd, J = 8.6 and 6.8 Hz, 
4
J = 
1.1 Hz, 1H, FCCCHCHCH), 7.9 (dd, J = 8.3 Hz, 
4
J(H,F) =, 5.6 Hz, 
FCCHCH), 8.2 (d, J = 8.3 Hz, 1H, FCCCH), 8.96 (d, J = 8.6 Hz, 
1H, FCCCCH);
 13
C-NMR (75 MHz, CDCl3):  13.6, 13.8, 21.8, 
22.5, 29.9 (2C), 32.6, 37, 108.2 (d, 
2
J(C,F) = 21 Hz), 120.9 (d, 
3
J(C,F) = 6.4 Hz), 124.2 (d, 
2
J(C,F) = 15.7 Hz), 125.8 (d, 
4
J(C,F) = 2 
Hz), 127 (d, 
4
J(C,F) = 1.6 Hz), 129.5, 130.3 (d, 
4
J(C,F) = 4.2 Hz), 
132.3 (d, 
3
J(C,F) = 10.1 Hz), 132.7 (d, 
3
J(C,F) = 5.6 Hz), 138.9, 
139.8, 161.7 (d, 
1
J(C,F) = 261.5 Hz), 197.9; EI-MS m/z: 346 (M
+
, 
0.4 %), 311 (22), 310 (100), 268 (40), 267 (90), 255 (11), 254 
(32), 253 (18), 239 (13), 226 (31), 225 (80), 213 (14), 212 (47), 
211 (67), 209 (16), 207 (22), 197 (36), 196 (47), 183 (32), 170 
(11). HRMS calcd. for C21H24ClFO: 346.1500; found: 346.1474. 
 
4.3.10.  (Z)-2-Butyl-3-chloro-1-(thiophen-2-yl)hept-2-en-1-
one (3j): pale yellow oil; Rf = 0.67 (hexane/ethyl acetate 4:1); tr 
14.9; IR (cm
-1
): 1644, 1514, 1409, 1274, 1049, 722; 
1
H-NMR 
(300 MHz, CDCl3):  0.79, 0.88 (2t, J = 7.3 and 7.2 Hz 
respectively, 3H each one, CH3 × 2), 1.15-1.25, 1.3-1.4, 1.4-1.45, 
1.45-1.55 (4m, 2H each one, CH2 × 4), 2.26 (t, J = 7.2 Hz, 2H, 
ClCCH2), 2.52 (t, J = 7.4 Hz, 2H, ClCCCH2), 7.15 (dd, J = 4.9 
and 3.8 Hz, 1H, SCHCH), 7.63 (dd, J = 3.8 Hz, 
4
J = 1.1 Hz, 1H, 
SCCH), 7.72 (dd, J = 4.9 Hz, 
4
J = 1.1 Hz, 1H, SCH);
 13
C-NMR 
(75 MHz, CDCl3):  13.7, 13.8, 21.7, 22.5, 29.7, 29.8, 32.4, 37.1, 
128.3, 134.3, 135.2, 137, 137.1, 144, 189.7; EI-MS m/z: 284 (M
+
, 
9 %), 253 (19), 251 (57), 241 (12), 111 (100). HRMS calcd. for 
C15H21ClOS: 284.1002; found: 284.1028. 
 
4.3.11.  (Z)-3-Chloro-1-(4-methoxyphenyl)-2,3-diphenylprop-
en-1-one (3k): orange oil; Rf = 0.33 (hexane/ethyl acetate 4:1); tr 
22.5; IR (cm
-1
): 1604, 1509, 1346, 1249, 1175, 1028, 753, 696; 
1
H-NMR (300 MHz, CDCl3):  3.83 (s, 3H, OCH3), 6.92 (d, J = 
8.9 Hz, 2H, OCCH × 2), 7.15-7.4 (m, 12H, Ph × 2 and OCCHCH 
× 2);
 13
C-NMR (75 MHz, CDCl3):  55.2, 114.1 (2C), 121.2, 
122.7, 127.5 (2C), 128 (2C), 129.8 (2C), 130.2 (2C), 131, 131.1, 
131.6, 133.2 (2C), 145.1, 155.1, 160.4, 196.4; EI-MS m/z: 313 
(25 %), 312 (100), 311 (24), 281 (22), 268 (11), 240 (10), 239 
(29). HRMS calcd. for C22H17ClO2-HCl: 312.1150; found: 
312.1113.  
 
4.3.12. (Z)-4-Butyl-5-chloro-1-phenylnon-4-en-3-one and 
(E)-4-Butyl-5-chloro-1-phenylnon-4-en-3-one [(Z)-3l/(E)-4l: 
3/1]: brown oil; Rf = 0.73 (hexane/ethyl acetate 4:1); tr 15.6; IR 
(cm
-1
): 1697, 1603, 1496, 1454, 747, 698; 
1
H-NMR (300 MHz, 
CDCl3):  0.85-1 (m, 8H, CH3 × 4), 1.2-1.6 (m, 11H, CH2 × 8), 
2.15-2.45 (m, 5H, CH2 × 4), 2.85-3 (m, 5H, CH2 × 4), 7.2-7.35 
(m, 7H, Ph × 2);
 13
C-NMR (75 MHz, CDCl3):  13.7, 13.8, 13.9, 
13.9, 21.9, 22, 22.4, 22.5, 29.5, 29.7, 29.8, 29.8, 29.9, 30.2, 30.6, 
30.9, 34.6, 36.6, 43.9, 44.6, 126, 126.2, 128.3 (2C), 128.4 (2C), 
128.4 (2C), 128.5 (2C), 132, 138.8, 139.2, 140.1, 140.8, 141.1, 
204.2 (C=O, Z), 206.2 (C=O, E); EI-MS m/z: 270 (19 %), 241 
(42), 180 (13), 179 (100), 166 (12), 137 (39), 105 (66), 91 (63). 
HRMS calcd. for C19H27ClO-HCl: 270.1984; found: 270.1973. 
 
4.3.13.  (Z)-2-Butyl-3-chloro-1-(naphthalen-1-yl) hept-2-en-
1-one (3m): orange oil; Rf = 0.73 (hexane/ethyl acetate 4:1); tr 
18.8; IR (cm
-1
): 1699, 1582, 1519, 1458, 1259, 1069, 1019, 822, 
797; 
1
H-NMR (300 MHz, CDCl3):  0.96, 1.01 (2t, J = 7.2 and 
7.3 Hz, respectively, 3H each one, CH3 × 2), 1.35-1.45, 1.45-
1.55, 1.6-1.7 (3m, 2, 4 and 2H, respectively, CH2 × 4), 2.28, 2.59 
(2t, J = 7.2 and 7.5 Hz, respectively, 2H each one, CCH2 × 2), 
7.25-7.35, 7.45-7.5, 7.7-7.75, 7.85-7.9, 8.65-8.7 (5m, 3, 1, 1, 1 
and 1H, respectively, ArH × 7);
 13
C-NMR (75 MHz, CDCl3):  
13.9, 14, 22.6, 22.8, 23, 25.9, 30, 31.7, 117.7, 122.8, 123.5, 
125.3, 128.2, 128.8 (2C), 133.4, 133.9, 134, 147, 155.6, 200.8; 
EI-MS m/z: 293 (M
+
-Cl, 22 %), 292 (94), 250 (39), 249 (100), 
236 (20), 235 (19), 221 (11), 208 (23), 207 (79), 202 (11), 195 
(18), 194 (52), 193 (85), 191 (19), 190 (10), 189 (19), 179 (49), 
178 (62), 177 (11), 176 (15), 165 (41), 152 (16). HRMS calcd. 
for C21H25ClO-HCl: 292.1827; found: 292.1834. 
 
4.3.14.  (E)-2-Butyl-3-chloro-1-phenylhept-2-en-1-one (4a): 
pale yellow oil; Rf = 0.73 (hexane/ethyl acetate 4:1); tr 14.6; IR 
(cm
-1
): 1668, 1636, 1596, 1579, 1465, 1448, 1268, 1213, 935, 
720, 690;
 1
H-NMR (300 MHz, CDCl3):  0.89, 0.99 (2t, J = 7.6 
and 7.3 Hz, respectively, 3H each one, CH3 × 2), 1.3-1.55, 1.6-
1.7 (2m, 6 and 2H, respectively, CH2 × 4), 2.35-2.4, 2.45-2.5 
(2m, 2H each one, CCH2 × 2), 7.45-7.5 (m, 2H, OCCCHCH × 2), 
7.55-7.65 (m, 1H, OCCCHCHCH), 7.85-7.95 (m, 2H, OCCCH × 
2);
 13
C-NMR (75 MHz, CDCl3):  13.7, 13.9, 22.2, 22.6, 29.6, 
30.5, 31.4, 34.5, 128.7 (2C), 129.4 (2C), 133.4, 135.7, 136.6, 
137, 197.3; EI-MS m/z: 280 (M
+
+2, 11 %), 279 (M
+
+1, 10), 278 
(M
+
, 33), 277 (11), 243 (32), 235 (17), 201 (11), 199 (12), 187 
(11), 179 (18), 145 (14), 105 (100), 77 (50). HRMS calcd. for 
C17H23ClO: 278.1437; found: 278.1428. 
 
4.3.15.  (Z)-3-Bromo-2-butyl-1-phenylhept-2-en-1-one (6): 
brown oil; Rf = 0.77 (hexane/ethyl acetate 4:1); tr 14.3; IR (cm
-1
): 
1668, 1631, 1596, 1580, 1463, 1449, 1313, 1264, 1211, 934, 716, 
688; 
1
H-NMR (300 MHz, CDCl3):  0.68, 0.78 (2t, J = 7.3 and 
7.1 Hz, respectively, 3H each one, CH3 × 2), 1.1-1.15, 1.15-1.35, 
1.35-1.5 (3m, 2, 4 and 2H, respectively, CH2 × 4), 2.20 (t, J = 7.3 
Hz, 2H, ClCCH2), 2.41 (t, J = 7.2 Hz, 2H, ClCCCH2), 7.35-7.45 
(m, 2H, OCCCHCH × 2), 7.45-7.55 (m, 1H, OCCCHCHCH), 
7.8-7.85 (m, 2H, OCCCH × 2);
 13
C-NMR (75 MHz, CDCl3):  
13.6, 13.7, 21.6, 22.4, 29.4, 30.6, 35.3, 38.9, 128.7 (2C), 129.4 
(2C), 130.4, 133.7, 136, 139.8, 197.1; EI-MS m/z: 243 (1 %), 242 
(5), 213 (12), 105 (100), 77 (29). HRMS calcd. for C17H23BrO: 
322.0932; found: 322.0910. 
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4.3.16. cis-2,3-Dibutyl-5-chloro-4-phenylcyclopent-2-enone 
(8a): yellow oil; Rf = 0.63 (hexane/ethyl acetate 4:1); tr 16.5; IR 
(cm
-1
): 1714, 1632, 1603, 1496, 1455, 1346, 751, 700; 
1
H-NMR 
(300 MHz, CDCl3):  0.76 (t, J = 7.1 Hz, 3H, 
OCCCH2CH2CH2CH3), 0.86 (t, J = 7.2 Hz, 3H, 
OCCCCH2CH2CH2CH3), 1.1-1.45 (m, 8H, CH2 × 4), 1.9 (ddd, 
2
J 
= 14 Hz, J = 8.7 and 5.3 Hz, 1H, OCCCCH2), 2.15-2.3 (m, 2H, 
OCCCH2), 2.41 (ddd, 
2
J = 14 Hz, J = 9.4 and 6.2 Hz, 1H, 
OCCCCH2), 3.90 (d, J = 2.7 Hz, 1H, OCCHCH), 3.98 (d, J = 2.7 
Hz, 1H, OCCH), 7-7.05 (m, 2H, ClCHCHCCH × 2), 7.15-7.3 (m, 
3H, ClCHCHCCHCH × 2 and ClCHCHCCHCHCH);
 13
C-NMR 
(75 MHz, CDCl3):  13.6, 13.8, 22.5, 22.6, 23.3, 28.5, 29.1, 30.6, 
57.7, 62.1, 127.5 (2C), 127.8, 129.1 (2C), 138.9, 139.9, 172.6, 
201.1; EI-MS m/z: 306 (M
+
+2, 18 %), 305 (M
+
+1, 12), 304 (M
+
, 
54), 277 (24), 276 (14), 275 (71), 270 (21), 269 (100), 247 (13), 
227 (13), 185 (11), 183 (11), 155 (14), 153 (10), 141 (21), 129 
(17), 128 (14), 115 (17), 103 (12), 91 (32), 77 (13). HRMS calcd. 
for C19H25ClO: 304.1594; found: 304.1645. 
 
4.3.17. cis-5-Chloro-2,3-diethyl-4-phenylcyclopent-2-enone 
(8b): yellow oil; Rf = 0.37 (hexane/ethyl acetate 4:1); tr 14.5; IR 
(cm
-1
): 1713, 1633, 1603, 1495, 1455, 1354, 760, 728, 700; 
1
H-
NMR (300 MHz, CDCl3):  0.99 (t, J = 7.6 Hz, 3H, 
OCCCCH2CH3), 1.1 (t, J = 7.6 Hz, 3H, OCCCH2CH3), 2.02 (dq, 
2
J = 14.5 Hz, J = 7.6 Hz, 1H, OCCCCH2), 2.35 (q, J = 7.6 Hz, 
2H, OCCCH2), 2.53 (dq, 
2
J = 14.5 Hz, J = 7.6 Hz, 1H, 
OCCCCH2), 4.01 (d, J = 2.7 Hz, 1H, OCCHCH), 4.08 (d, J = 2.7 
Hz, 1H, OCCH), 7.1-7.15 (m, 2H, ClCHCHCCH × 2), 7.3-7.4 
(m, 3H, ClCHCHCCHCH × 2 and ClCHCHCCHCHCH); 
13
C-
NMR (75 MHz, CDCl3):  11.7, 13.1, 16.8, 21.9, 57.4, 62.2, 
127.5 (2C), 127.8, 129.1 (2C), 138.7, 140.7, 173.4, 201; EI-MS 
m/z: 250 (M
+
+2, 14 %), 248 (M
+
, 42), 219 (11), 214 (16), 213 
(100), 185 (16), 143 (14), 141 (12), 129 (28), 128 (15), 115 (17), 
91 (16), 77 (14). HRMS calcd. for C15H17ClO: 248.0968; found: 
248.0930. 
 
4.3.18. cis-5-Chloro-2,3-dipentyl-4-phenylcyclopent-2-enone 
(8c): yellow oil; Rf = 0.63 (hexane/ethyl acetate 4:1); tr 17.5; IR 
(cm
-1
): 1715, 1632, 1603, 1496, 1455, 1358, 748, 728, 700; 
1
H-
NMR (300 MHz, CDCl3):  0.83, 0.91 (2t, J = 6.9 Hz each one, 
3H each one, CH3 × 2), 1.15-1.25, 1.25-1.4, 1.4-1.55 (3m, 4H 
each one, CH2 × 6), 1.98 (ddd, 
2
J = 13.8 Hz, J = 9.2 and 5.3 Hz, 
1H, OCCCCH2), 2.2-2.4 (m, 2H, OCCCH2), 2.47 (ddd, 
2
J = 13.8, 
Hz, J = 9.4 and 6.6 Hz, 1H, OCCCCH2), 3.98 (d, J = 2.7 Hz, 1H, 
OCCHCH), 4.06 (d, J = 2.7 Hz, 1H, OCCH), 7.1-7.15 (m, 2H, 
ClCHCHCCH × 2), 7.3-7.4 (m, 3H, ClCHCHCCHCH × 2 and 
ClCHCHCCHCHCH); 
13
C-NMR (75 MHz, CDCl3):  13.7, 13.9, 
22.2, 22.4, 23.5, 26.6, 28.1, 28.8, 31.5, 31.7, 57.8, 62.1, 127.5 
(2C), 127.8, 129.1 (2C), 138.9, 139.9, 172.6, 201.1; EI-MS m/z: 
334 (M
+
+2, 18 %), 333 (M
+
+1, 13), 332 (M
+
, 52), 298 (24), 297 
(100), 291 (27), 290 (16), 289 (79), 263(14), 261 (39), 241 (18), 
185 (14), 183 (15), 165 (10), 155 (17), 153 (13), 141 (26), 129 
(18), 128 (17), 115 (19), 103 (14), 91 (44), 77 (14). HRMS calcd. 
for C21H29ClO: 332.1907; found: 332.1912. 
 
4.3.19. cis-3-(tert-Butyl)-5-chloro-2-methyl-4-
phenylcyclopent-2-enone (8d): pale yellow oil; Rf = 0.73 
(hexane/ethyl acetate 4:1); tr 14.7; IR (cm
-1
): 1713, 1636, 1603, 
1495, 1484, 1455, 1313, 1143, 1022, 966, 759, 700; 
1
H-NMR 
(300 MHz, CDCl3):  1.37 (s, 9H, C(CH3)3), 2 (d, 
5
J = 0.7 Hz, 
3H, CH3), 3.79 (dd, J = 2.8 Hz, 
5
J = 0.7 Hz, 1H, OCCHCH), 3.99 
(d, J = 2.8 Hz, 1H, OCCH), 7.1-7.15, 7.3-7.4 (2m, 2 and 3H, 
respectively, Ph); 
13
C-NMR (75 MHz, CDCl3):  18.3, 29.5 (3C), 
34, 60.6, 62.2, 127.6 (2C), 127.9, 129.2 (2C), 139.3, 145.3, 166, 
200.8; EI-MS m/z: 264 (M
+
+2, 16 %), 262 (M
+
, 47), 247 (16), 
228 (18), 227 (100), 200 (15), 199 (91), 185 (17), 183 (12), 169 
(13), 165 (13), 157 (16), 155 (12), 153 (11), 143 (15), 142 (12), 
141 (19), 129 (15), 128 (21), 115 (15), 105 (18), 103 (14), 91 
(26), 77 (18). HRMS calcd. for C16H19ClO: 262.1124; found: 
262.1080. 
 
4.3.20. trans-3-(tert-Butyl)-5-chloro-2-methyl-4-
phenylcyclopent-2-enone (8d’): pale yellow oil; Rf = 0.67 
(hexane/ethyl acetate 4:1); tr 14.8; IR (cm
-1
): 1712, 1649, 1602, 
1494, 1479, 1465, 1241, 703; 
1
H-NMR (300 MHz, CDCl3):  
1.13 (s, 9H, C(CH3)3), 2.08 (d, 
5
J = 1.6 Hz, 3H, CH3), 3.83 (d, J = 
1 Hz, 1H, OCCH), 4.15-4.2 (m, 1H, OCCHCH), 7.05-7.15, 7.25-
7.35 (2m, 2 and 3H, respectively, Ph); 
13
C-NMR (75 MHz, 
CDCl3):  11.1, 29 (3C), 36.1, 58.4, 59.5, 127.2 (2C), 127.7, 
129.1 (2C), 135, 140.6, 178.4, 203.4; EI-MS m/z: 262 (M
+
, 21 
%), 247 (11), 228 (11), 227 (61), 205 (11), 169 (11), 141 (17), 
128 (10), 125 (10), 124 (100), 123 (14), 115 (12), 109 (50), 103 
(11), 91 (15), 81 (24), 77 (14). HRMS calcd. for C16H19ClO: 
262.1124; found: 262.1116. 
 
4.3.21. cis-2,3-Dibutyl-5-chloro-4-(4-fluorophenyl)cyclopent-
2-enone (8e): yellow oil; Rf = 0.67 (hexane/ethyl acetate 4:1); tr 
16.3; IR (cm
-1
): 1715, 1633, 1605, 1508, 1464, 1458, 1348, 1227, 
1159, 1097, 823, 789, 733; 
1
H-NMR (300 MHz, CDCl3):  0.85 
(t, J = 7.1 Hz, 3H, OCCCH2CH2CH2CH3), 0.94 (t, J = 7.1 Hz, 
3H, OCCCCH2CH2CH2CH3), 1.2-1.5 (m, 8H, CH2 × 4), 1.96 
(ddd, 
2
J = 13.7 Hz, J = 8.6, 4.7 Hz, 1H, OCCCCH2), 2.2-2.35 (m, 
2H, OCCCH2), 2.49 (ddd, 
2
J = 13.7 Hz, J = 9.2 and 5.7 Hz, 1H, 
OCCCCH2), 3.97 (d, J = 2.8 Hz, 1H, OCCHCH), 4.01 (d, J = 2.8 
Hz, 1H, OCCH), 7-7.15 (m, 4H, ArH × 4);
 13
C-NMR (75 MHz, 
CDCl3):  2.8, 3, 13.2, 13.3, 14.1, 20.1, 20.9, 22.6, 53.6, 59.6, 
122.9 (d, 
2
J(C,F) = 25.3 Hz, 2C), 138.1 (d, 
3
J(C,F) = 9.6 Hz, 2C), 
144.6 (d, 
4
J(C,F) = 3.8 Hz), 151.1, 177 (d, 
1
J(C,F) = 289.5 Hz), 
188.5, 222.1; EI-MS m/z: 324 (M
+
+2, 16 %), 323 (M
+
+1, 10), 
322 (M
+
, 48), 295 (24), 294 (13), 293 (72), 288 (22), 287 (100), 
265 (13), 245 (11), 203 (11), 201 (11), 159 (20), 147 (12), 146 
(13), 133 (14), 109 (34), 91 (14). HRMS calcd. for C19H24ClFO: 
322.1500; found: 322.1489. 
 
4.3.22. cis-2,3-Dibutyl-5-chloro-4-(4-
methoxyphenyl)cyclopent-2-enone (8f): pale yellow oil; Rf = 0.53 
(hexane/ethyl acetate 4:1); tr 18.1; IR (cm
-1
): 1713, 1631, 1611, 
1511, 1463, 1249, 1176, 1033, 820; 
1
H-NMR (300 MHz, CDCl3): 
 0.85, 0.94 (2t, J = 7.1 Hz each one, 3H each one, CH2CH3 × 2), 
1.15-1.5 (m, 8H, CH2 × 4), 1.99 (ddd, 
2
J = 13.8 Hz, J = 8.8 and 5 
Hz, 1H, OCCCCH2), 2.2-2.4 (m, 2H, OCCCH2), 2.48 (ddd, 
2
J = 
13.8 Hz, J = 9.3 and 6.1 Hz, 1H, OCCCCH2), 3.81 (s, 3H, 
OCH3), 3.93 (d, J = 2.7 Hz, 1H, OCCHCH), 4.02 (d, J = 2.7 Hz, 
1H, OCCH), 6.89 (d, J = 8.6 Hz, 2H, CH3OCCH × 2), 7.03 (d, J 
= 8.6 Hz, 2H, CH3OCCHCH × 2); 
13
C-NMR (75 MHz, CDCl3):  
13.7, 13.9, 22.6, 22.7, 23.3, 28.5, 29.2, 30.6, 55.3, 57, 62.3, 114.6 
(2C), 128.6 (2C), 130.9, 139.7, 159.2, 172.9, 201.3; EI-MS m/z: 
336 (M
+
+2, 18 %), 335 (M
+
+1, 12), 334 (M
+
, 49), 305 (19), 300 
(33), 299 (100), 279 (16), 277 (47), 271 (19), 269 (14), 255 (17), 
243 (11), 207 (30), 171 (11), 121 (29). HRMS calcd. for 
C20H27ClO2: 334.1700; found: 334.1666. 
 
4.3.23. 2-Methyl-3-phenyl-1H-cyclopenta[a]naphthalen-1-
one (10a): orange solid; m.p. 117-120 ºC (hexane); Rf = 0.63 
(hexane/ethyl acetate 4:1); tr 19.7; IR (cm
-1
): 1698, 1628, 1581, 
1565, 1519, 1440, 1329, 1217, 1066, 834, 753, 701; 
1
H-NMR 
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(300 MHz, CDCl3):  1.95 (s, 3H, CH3), 7.25 (d, J = 8.1 Hz, 1H, 
OCCCCHCHC), 7.34 (t, J = 8.5 Hz, 1H, OCCCCHCHCH), 7.45-
7.6 (m, 6H, Ph and OCCCCHCHCH), 7.69 (d, J = 8.3 Hz, 1H, 
OCCCCCHCHCH), 7.78 (d, J = 8.1 Hz, 1H, OCCCCHCHC), 
8.77 (d, J = 8.5 Hz, 1H, OCCCCHCHCH); 
13
C-NMR (75 MHz, 
CDCl3):  8.4, 118.8, 122.7, 123.5, 125.5, 127.9 (2C), 128.2, 
128.6 (2C), 128.9 (2C), 129.1, 129.7, 132.6, 133.7, 133.9, 147, 
152.7, 200.1; EI-MS m/z: 271 (M
+
+1, 20 %), 270 (M
+
, 100), 269 
(41), 253 (11), 242 (22), 241 (46), 240 (17), 239 (46), 226 (13), 
215 (15), 120 (17). HRMS calcd. for C20H14O: 270.1045; found: 
270.1037. Crystal data: C20H14O, M = 270.31; Crystal size max = 
0.25, mid = 0.24, min = 0.03; Monoclinic, space group P21/c, a = 
12.714 (17), b = 13.994 (18), c = 8.433 (11) Å,  = 90º, β = 
108.49º (3), γ = 90º; V = 1423 (3) Å
3
; ρcalcd = 1.262 g/cm
3
; 2θmax = 
50.42; radiation type: Mo, λ = 0.71073 Å; data collection based 
on three ω-scan runs (starting ω = -34º) at values Φ = 0º, 120º, 
240º with the detector at 2θ = -32º. An additional run of 100 
frames, at 2θ = -32º, ω = -34º and Φ = 0º, was acquired to 
improve redundancy. For each of these runs, 606 frames were 
collected at 0.3º intervals and 30 s per frame. T = 25±1ºC, 
measured and independent reflections = 2522, reflections 
included in refinement = 10535, I > 2/σ. The diffraction frames 
were integrated using the program SAINT and the integrated 
intensities were corrected for Lorentz-polarization effects with 
SADABS, μ = 0.076, transmission min = 0.7266, transmission 
max = 0.9977. The structure was solved by direct methods and 
refined to unique F
2
 by full matrix least squares. No. of 
parameters = 192 All of the hydrogen atoms were placed at 
idealized positions and retained as rigid atoms. R = 0.0718, wR = 
0.1323, residual electron density = 0.519. All results were 
deposited at Cambridge Crystallographic Data Centre. 
 
4.3.24. 2-Butyl-3-phenyl-1H-cyclopenta[a]naphthalen-1-one 
(10b): orange oil; Rf = 0.6 (hexane/ethyl acetate 4:1); tr 21.8; IR 
(cm
-1
): 1697, 1628, 1579, 1518, 1492, 1441, 1367, 1334, 1158, 
1088, 1049, 1023, 827, 799, 744, 698; 
1
H-NMR (300 MHz, 
CDCl3):  0.85 (t, J = 7.3 Hz, 3H, CH3), 1.25-1.4, 1.45-1.55 (2m, 
2H each one, CH2 × 2), 2.33 (t, J = 7.5 Hz, 2H, CCH2), 7.15 (d, J 
= 8.1 Hz, 1H, OCCCCHCHC), 7.29 (ddd, J = 8.3 and 6.8 Hz, 
4
J 
= 1.2 Hz, 1H, OCCCCHCHCH), 7.4-7.55 (m, 6H, Ph and 
OCCCCHCHCH), 7.65 (d, J = 8.4 Hz, 1H, OCCCCCHCHCH), 
7.74 (d, J = 8.1 Hz, 1H, OCCCCHCHC), 8.73 (dd, J = 8.3 Hz, 
4
J 
= 0.9 Hz, 1H, OCCCCHCHCH); 
13
C-NMR (75 MHz, CDCl3):  
13.8, 22.8, 22.9, 31.6, 118.9, 122.5, 123.5, 125.5, 127.7 (2C), 
128.3, 128.7 (2C), 128.9, 129, 129.1, 132.9, 133.8, 134.1, 134.3, 
147.2, 153.1, 200.3; EI-MS m/z: 313 (M
+
+1, 20 %), 312 (M
+
, 
80), 271 (10), 270 (47), 269 (100), 268 (10), 257 (13), 256 (19), 
252 (18), 251 (14), 250 (12), 241 (20), 240 (21), 239 (63), 226 
(12). HRMS calcd. for C23H20O: 312.1514; found: 312.1470. 
 
4.3.25. 2-Methyl-3-(p-tolyl)-1H-cyclopenta[a]naphthalen-1-
one (10c): brown oil; Rf = 0.5 (hexane/ethyl acetate 4:1); tr 20.9; 
IR (cm
-1
): 1697, 1621, 1580, 1509, 1439, 1377, 1329, 1239, 
1187, 1158, 1064, 913, 825, 811, 757; 
1
H-NMR (300 MHz, 
CDCl3):  1.93 (s, 3H, OCCCH3), 2.45 (s, 3H, CHCCH3), 7.29 
(d, J = 8.1 Hz, 1H, OCCCCHCHC), 7.3-7.35 (m, 3H, CH3CCH × 
2 and OCCCCHCHCH), 7.42 (d, J = 8.2 Hz, 2H, CH3CCHCH × 
2), 7.50 (ddd, J = 8.5 and 6.8 Hz, 
4
J = 1.3 Hz, 1H, 
OCCCCHCHCH), 7.7 (d, J = 8.5 Hz, 1H, OCCCCCHCHCH), 
7.81 (d, J = 8.1 Hz, 1H, OCCCCHCHC), 8.75 (dd, J = 8.5 Hz, 
4
J 
= 1.3 Hz, 1H, OCCCCHCHCH); 
13
C-NMR (75 MHz, CDCl3):  
8.5, 21.5, 118.9, 123, 123.7, 125.6, 128 (2C), 128.3, 129, 129.2, 
129.4, 129.5, 129.4 (2C), 129.5, 129.9, 133.7, 134, 139.2, 147.3, 
153, 200.4; EI-MS m/z: 285 (M
+
+1, 23 %), 284 (M
+
, 100), 283 
(29), 269 (38), 255 (12), 252 (10), 241 (18), 240 (15), 239 (37), 
207 (17), 119 (11). HRMS calcd. for C21H16O: 284.1201; found: 
284.1237. 
 
4.3.26.  (E)-2-Ethyl-3-ethylidene-2,3-dihydro-1H-
cyclopenta[a]naphthalen-1-one (11a): pale yellow solid; m.p. 
94-96 ºC; Rf = 0.5 (hexane/ethyl acetate 4:1); tr 16.8; IR (cm
-1
): 
1687, 1620, 1587, 1513, 1440, 1186, 815, 748; 
1
H-NMR (300 
MHz, CDCl3):  0.81 (t, J = 7.5 Hz, 3H, CH2CH3), 1.95-2.05 (m 
with d at 2, J = 7.2 Hz, 1 and 3H, respectively, CH2CH3 and 
CHCH3), 2.15-2.25 (m, 1H, CH2CH3), 3.3-3.35 (m 1H, 
CHCH2CH3), 6.45 (qd, J = 7.2 Hz, 
4
J = 1.6 Hz, 1H, CHCH3), 
7.54 (ddd, J = 8.1 and 7 Hz, 
4
J = 1.3 Hz, 1H, OCCCCHCHCH), 
7.68 (ddd, J = 8.4 and 7 Hz, 
4
J = 1.4 Hz, 1H, OCCCCHCHCH), 
7.75 (d, J = 8.6 Hz, 1H, CH3CHCCCH), 7.87 (d, J = 8.1 Hz, 1H, 
OCCCCCHCHCH), 8.01 (d, J = 8.6 Hz, 1H, CH3CHCCCHCH), 
9.19 (d, J = 8.4 Hz, 1H, OCCCCHCHCH); 
13
C-NMR (75 MHz, 
CDCl3):  9.2, 15.1, 23.7, 50.2, 117.9, 120.3, 124.8, 126.6, 128, 
129, 129.1, 129.5, 133, 135.7, 137.2, 152.9, 207; EI-MS m/z: 236 
(M
+
, 36 %), 209 (17), 208 (100), 193 (16), 179 (21), 178 (42), 
165 (22). HRMS calcd. for C17H16O: 236.1201; found: 236.1179. 
Crystal data: C17H16O, M = 236.30; Crystal size max = 0.16, mid 
= 0.14, min = 0.04; Triclinic, space group P1, a = 5.268 (4), b = 
7.674 (6), c = 25.24 (2) Å,  = 86.224º (13), β = 84.914º (14), γ = 
71.474º (14); V = 9630 (13) Å
3
; ρcalcd = 1.222 g/cm
3
; 2θmax = 50.1; 
radiation type: Mo, λ = 0.71073 Å; data collection based on three 
ω-scan runs (starting ω = -34º) at values Φ = 0º, 120º, 240º with 
the detector at 2θ = -32º. An additional run of 100 frames, at 2θ = 
-32º, ω = -34º and Φ = 0º, was acquired to improve redundancy. 
For each of these runs, 606 frames were collected at 0.3º intervals 
and 30 s per frame. T = 24±1ºC, measured and independent 
reflections = 6371, reflections included in refinement = 8052, I > 
2/σ. The diffraction frames were integrated using the program 
SAINT and the integrated intensities were corrected for Lorentz-
polarization effects with SADABS, μ = 0.074, transmission min 
= 0.828, transmission max = 0.997. The structure was solved by 
direct methods and refined to unique F
2
 by full matrix least 
squares. No. of parameters = 493 All of the hydrogen atoms were 
placed at idealized positions and retained as rigid atoms. R = 
0.0718, wR = 0.1323, residual electron density = 0.161. All 
results were deposited at Cambridge Crystallographic Data 
Centre. 
 
4.3.27.  (E)-2-Butyl-3-butylidene-2,3-dihydro-1H-
cyclopenta[a]naphthalen-1-one (11b): orange oil; Rf = 0.57 
(hexane/ethyl acetate 4:1); tr 19.1; IR (cm
-1
): 1693, 1621, 1587, 
1514, 1456, 1439, 1184, 821, 750; 
1
H-NMR (300 MHz, CDCl3): 
 0.83, 1.05 (2t, J = 7 and 7.4 Hz, respectively, 3H each one, CH3 
× 2), 1.2-1.35, 1.55-1.65 (2m, 4 and 2H, respectively, CH2 × 3), 
1.85-1.95, 2.05-2.15 (2m, 1H each one, OCCHCH2), 2.25-2.45 
(m, 2H, OCCHCCHCH2), 3.3-3.4 (m 1H, OCCH), 6.36 (td, J = 
7.6 Hz, 
4
J = 1.5 Hz, 1H, OCCHCCH), 7.55 (t, J = 7.5 Hz, 1H, 
OCCCCHCHCH), 7.68 (t, J = 7.5 Hz, 1H, OCCCCHCHCH), 
7.78 (d, J = 8.6 Hz, 1H, OCCCCHCHC), 7.88 (d, J = 8.2 Hz, 1H, 
OCCCCCHCHCH), 8.03 (d, J = 8.6 Hz, 1H, OCCCCHCHC), 
9.19 (d, J = 8.4 Hz, 1H, OCCCCHCHCH); 
13
C-NMR (75 MHz, 
CDCl3):  13.8, 14, 22.8, 23, 26.9, 30.9, 31.6, 49.6, 118.1, 124.9, 
125.8, 126.6, 128.1, 129.1, 129.2, 129.5, 133.1, 135.7, 136.7, 
152.8, 207.1; EI-MS m/z: 292 (M
+
, 23 %), 250 (23), 249 (17), 
237 (19), 236 (100), 221 (19), 209 (11), 208 (63), 207 (28), 194 
(32), 191 (12), 189 (11), 179 (31), 178 (39), 165 (26), 152 (11). 
HRMS calcd. for C21H24O: 292.1827; found: 292.1807. 
 
4.3.28.  (E)-2-Pentyl-3-pentylidene-2,3-dihydro-1H-
cyclopenta[a]naphthalen-1-one (11c): pale yellow oil; Rf = 0.67 
(hexane/ethyl acetate 4:1); tr 21; IR (cm
-1
): 1693, 1620, 1587, 
1515, 1457, 1439, 1183, 822, 751; 
1
H-NMR (300 MHz, CDCl3): 
 0.8, 0.96 (2t, J = 6.9 and 7.2 Hz, respectively, 3H each one, 
CH3 × 2), 1.1-1.35, 1.4-1.45, 1.5-1.55 (3m, 6, 2 and 2H, 
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respectively, CH2 × 5), 1.8-1.9, 2.05-2.15 (2m, 1H each one, 
OCCHCH2), 2.3-2.4 (m, 2H, OCCHCCHCH2), 3.25-3.35 (m 1H, 
OCCH), 6.33 (dt, J = 7.6 Hz, 
4
J = 1.5 Hz, 1H, OCCHCCH), 7.53 
(ddd, J = 8.1 and 7.1 Hz, 
4
J = 1.2 Hz, 1H, OCCCCHCHCH), 
7.65 (ddd, J = 8.3 and 7.1 Hz, 
4
J = 1.2 Hz, 1H, 
OCCCCHCHCH), 7.76 (d, J = 8.7 Hz, 1H, OCCCCHCHC), 7.85 
(d, J = 8.1 Hz, 1H, OCCCCCHCHCH), 8.01 (d, J = 8.7 Hz, 1H, 
OCCCCHCHC), 9.15 (d, J = 8.3 Hz, 1H, OCCCCHCHCH); 
13
C-
NMR (75 MHz, CDCl3):  14 (2C), 22.4, 22.6, 24.4, 29.3, 31.2, 
31.7, 32.1, 49.6, 118.1, 124.9, 126.1, 126.6, 128.1, 129.1, 129.2, 
129.5, 133.1, 135.7, 136.6, 152.8, 207.1; EI-MS m/z: 320 (M
+
, 17 
%), 264 (19), 263 (18), 251 (12), 250 (60), 249 (10), 221 (14), 
209 (18), 208 (100), 207 (24), 195 (12), 194 (31), 191 (14), 189 
(13), 182 (23), 179 (35), 178 (46), 165 (29), 152 (11). HRMS 
calcd. for C23H28O: 320.2140; found: 320.2159. 
 
4.3.29. 1,1,2,3-Tetramethylphenanthren-4-(1H)-one (12): 
pale yellow oil; Rf = 0.53 (hexane/ethyl acetate 4:1); tr 17.1; IR 
(cm
-1
): 1701, 1633, 1616, 1595, 1508, 1457, 1378, 1284, 1071, 
827, 757; 
1
H-NMR (300 MHz, CDCl3):  1.54 (s, 6H, C(CH3)2), 
2.09 (q, 
5
J = 0.8 Hz, 3H, OCCCH3), 2.11 (q, 
5
J = 0.8 Hz, 3H, 
OCCCCH3), 7.53 (ddd, J = 8.1 and 6.8 Hz, 
4
J = 1.2 Hz, 1H, 
OCCCCHCHCH), 7.64 (ddd, J = 8.3 and 6.8 Hz, 
4
J = 1.6 Hz, 
1H, OCCCCHCHCH), 7.67 (d, J = 8.8 Hz, 1H, OCCCCHCHC), 
7.83 (d, J = 8 Hz, 1H, OCCCCCHCHCH), 7.99 (d, J = 8.8 Hz, 
1H, OCCCCHCHC), 9.79 (d, J = 8.3 Hz, 1H, OCCCCHCHCH); 
13
C-NMR (75 MHz, CDCl3):  12.3, 16.7, 28 (2C), 40.8, 124, 
124.7, 126.1, 127.7, 127.9, 128.4, 131.1, 132, 132.3, 133, 152.4, 
155.1, 186.8; EI-MS m/z: 251 (M
+
+1, 20 %), 250 (M
+
, 100), 236 
(16), 235 (85), 222 (19), 221 (11), 220 (19), 209 (36), 208 (21), 
207 (90), 193 (10), 192 (54), 191 (36), 190 (13), 189 (21), 179 
(14), 178 (15), 166 (12), 165 (27), 152 (14). HRMS calcd. for 
C18H18O: 250.1358; found: 250.1345. 
 
4.4. General Procedure for the Synthesis of Furans 
To a stirred solution of alkyne (2, 1 mmol) in dry toluene (2.5 
mL) under argon atmosphere were added Fe3O4 (25 mg) and the 
corresponding acid chloride (1, 1.5 mmol). The resulting mixture 
was stirred at 70 ºC during an hour. The catalyst was removed by 
a magnet and IrO2-Fe3O4 (25 mg) was added. The mixture was 
stirred at 130 ºC during three days. The catalyst was removed by 
a magnet and the resulting mixture was quenched with water (5 
mL) and extracted with EtOAc (3 × 5 mL). The organic phases 
were dried over MgSO4, followed by evaporation under reduced 
pressure to remove the solvent. The product was usually purified 
by chromatography on silica gel (hexane/ethyl acetate) to give 
the corresponding furans 13. Physical and spectroscopic data, as 
well as literature for known compound, follow: 
 
4.4.1. 3-Butyl-2-phenyl-5-propylfuran (13a): pale yellow 
oil; Rf = 0.77 (hexane/ethyl acetate 4:1); tr 14.3; IR (cm
-1
): 1600, 
1554, 1492, 1463, 1457, 1446, 801, 762, 692; 
1
H-NMR (300 
MHz, CDCl3):  1.01 (t, J = 7.3 Hz, 3H, CCH2CH2CH2CH3), 
1.06 (t, J = 7.4 Hz, 3H, CCH2CH2CH3), 1.48 (h, J = 7.3 Hz, 2H, 
CCH2CH2CH2CH3), 1.6-1.7 (m, 2H, CCH2CH2CH2CH3), 1.77 (h, 
J = 7.4 Hz, 2H, CCH2CH2CH3), 2.68, 2.69 (2t, J = 7.4 Hz each 
one, 2H each one, CCH2 × 2), 6.04 (s, 1H, OCCHC), 7.27 (t, J = 
7.4 Hz, 1H, OCCCHCHCH), 7.44 (t, J = 7.4 Hz, 2H, OCCCHCH 
× 2), 7.64 (d, 2H, J = 7.4 Hz, 2H, OCCCH × 2); 
13
C-NMR (75 
MHz, CDCl3):  13.8, 14, 21.4, 22.7, 25.7, 30.1, 32.2, 109, 122.4, 
125.2 (2C), 126.2, 128.4 (2C), 132.3, 146.4, 154.9; EI-MS m/z: 
243 (M
+
+1, 10 %), 242 (M
+
, 55), 214 (17), 213 (100), 200 (11), 
199 (20), 105 (25), 77 (20). HRMS calcd. for C17H22O: 242.1671; 
found: 242.1691. 
 
4.4.2. 3-Ethyl-5-methyl-2-phenylfuran (13b):
16
 colourless oil; 
Rf = 0.63 (hexane/ethyl acetate 4:1); tr 11.8; IR (cm
-1
): 1600, 
1557, 1492, 1444, 1071, 996, 761, 692; 
1
H-NMR (300 MHz, 
CDCl3):  1.26 (t, J = 7.5 Hz, 3H, CH2CH3), 2.36 (s, 3H, CCH3), 
2.68 (q, J = 7.5 Hz, 2H, CH2CH3), 6.03 (s, 1H, OCCHC), 7.2-7.3, 
7.35-7.45, 7.55-7.65 (3m, 2, 2 and 1H, Ph); 
13
C-NMR (75 MHz, 
CDCl3):  13.6, 14.5, 19.2, 109.2, 124, 125.2 (2C), 126.2, 128.4 
(2C), 132.1, 146.3, 150.7; EI-MS m/z: 187 (M
+
+1, 14 %), 186 
(M
+
, 100), 172 (11), 171 (87), 143 (18), 128 (31), 115 (11), 105 
(13), 77 (21).  
 
4.4.3. 3-Butyl-2-(4-chlorophenyl)-5-propylfuran (13c): pale 
yellow oil; Rf = 0.83 (hexane/ethyl acetate 4:1); tr 15.3; IR (cm
-1
): 
1568, 1549, 1487, 1464, 1094, 828; 
1
H-NMR (300 MHz, CDCl3): 
 0.97, 1.03 (2t, J = 7.2 and 7.3 Hz, respectively, 3H each one, 
CH3 × 2), 1.35-1.5, 1.55-1.65, 1.7-1.8 (3m, 2H each one, CH2 × 
3), 2.62, 2.64 (2t, J = 7.4 and 7.3 Hz, respectively, 2H each one, 
CCH2 × 2), 6.01 (s, 1H, OCCHC), 7.37 (d, J = 8.7 Hz, 2H, 
ClCCH × 2), 7.53 (d, J = 8.7 Hz, 2H, ClCCHCH × 2); 
13
C-NMR 
(75 MHz, CDCl3):  13.8, 13.9, 21.4, 22.6, 25.7, 30.1, 32.1, 
109.1, 123, 126.3 (2C), 128.6 (2C), 130.7, 131.7, 145.4, 155.2; 
EI-MS m/z: 277 (M
+
+1, 22 %), 276 (M
+
, 100), 255 (11), 253 
(35), 137 (12). HRMS calcd. for C17H21ClO: 276.1281; found: 
276.1214. 
 
4.4.4. 3-Butyl-2-(4-methoxyphenyl)-5-propylfuran (13d): 
yellow oil; Rf = 0.63 (hexane/ethyl acetate 4:1); tr 16; IR (cm
-1
): 
1606, 1577, 1559, 1505, 1462, 1293, 1247, 1176, 1037, 830, 801; 
1
H-NMR (300 MHz, CDCl3):  1.01, 1.07 (2t, J = 7.3 and 7.4 Hz, 
respectively, 3H each one, CH2CH3 × 2), 1.4-1.55, 1.6-1.7, 1.7-
1.85 (3m, 2H each one, CH2 × 3), 2.65, 2.68 (2t, J = 7.2 and 7.3 
Hz, respectively, 2H each one, CCH2 × 2), 3.87 (s, 3H, OCH3), 
6.03 (s, 1H, OCCHC), 7 (d, J = 9 Hz, 2H, OCCHCH × 2), 7.58 
(d, J = 9 Hz, 2H, OCCHCH × 2); 
13
C-NMR (75 MHz, CDCl3):  
13.8, 13.9, 21.4, 22.6, 25.6, 30.1, 32.3, 55.1, 108.6, 113.9 (2C), 
120.7, 125.2, 126.7 (2C), 146.4, 154.2, 158.1; EI-MS m/z: 273 
(M
+
+1, 13 %), 272 (M
+
, 66), 244 (17), 243 (100), 229 (21), 135 
(13). HRMS calcd. for C18H24O2: 272.1776; found: 272.1742. 
 
4.4.5. 3-Butyl-5-propyl-2-(thiophen-2-yl)furan (13e): pale 
yellow oil; Rf = 0.8 (hexane/ethyl acetate 4:1); tr 14.4; IR (cm
-1
): 
1566, 1464, 1378, 1258, 976, 848, 821, 687; 
1
H-NMR (300 MHz, 
CDCl3):  0.99, 1.03 (2t, J = 6.5 and 6.6 Hz, respectively, 3H 
each one, CH3 × 2), 1.35-1.5, 1.55-1.7, 1.7-1.8 (3m, 2H each one, 
CH2 × 3), 2.55-2.7 (m, 4H, CCH2 × 2), 6 (s, 1H, OCCHC), 7.08 
(dd, J = 5 and 3.7 Hz, 1H, SCHCH), 7.2 (dd, J = 3.7 Hz, 
4
J = 1.1 
Hz, 1H, SCCH), 7.23 (dd, J = 5 Hz, 
4
J = 1.1 Hz, 1H, SCH); 
13
C-
NMR (75 MHz, CDCl3):  13.8, 13.9, 21.4, 22.6, 25.5, 30.1, 
31.9, 108.7, 121.8, 122.1, 123, 127.2, 134.3, 142.7, 154.8; EI-MS 
m/z: 249 (M
+
+1, 10 %), 248 (M
+
, 57), 220 (15), 219 (100), 205 
(29), 111 (27). HRMS calcd. for C15H20OS: 248.1235; found: 
248.1228. 
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